Loss of Golgi function may contribute to pathology of neurodegenerative diseases

Disabling a part of brain cells that acts as a tap to regulate the flow of proteins has been shown to cause neurodegeneration, a new study from The University of Manchester has found.

The research, which was carried out in mice, focused on the Golgi apparatus - a compartment inside all cells in the body that controls the processing and transport of proteins. It is fundamental for the growth of the cell membrane and also for the release of many types of proteins such as hormones, neurotransmitters and the proteins that make up our skeletons.

Working with Chinese colleagues, the Manchester researchers examined the role of the Golgi apparatus in neurons, or brain cells, and found that mice in which the apparatus was disabled suffered from developmental delay, severe ataxia, and postnatal death.

Ataxia is a term for a group of disorders that affect co-ordination, balance and speech. Any part of the body can be affected, but people with ataxia often have difficulties with balance and walking, speaking, swallowing, tasks such as writing and eating, and vision. It can be inherited, brought on through incidents such as a stroke, or through old age.

Although the function of the Golgi apparatus, named after its Italian discoverer, is well understood, it has not been previously been shown to have a role in neurodegeneration.  With these results the scientists think they may have found a new avenue to explore in the search for the causes of some neurodegenerative diseases.

Professor Martin Lowe, the lead researcher, said: "Our results, combined with previous work, suggest that during the cellular changes that occur, loss of the Golgi function could be an important intermediary step that contributes to cell death."

How much the Golgi apparatus contributes to the major neurodegenerative diseases such as Alzheimer's or Parkinson's is something that is currently unclear, though other studies have made this link.

Professor Lowe added: "Together with other published work our findings suggest that in certain neurodegenerative diseases the loss of function of the Golgi apparatus may contribute to the pathology that is occurring."

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    The University of Manchester. (2019, June 18). Loss of Golgi function may contribute to pathology of neurodegenerative diseases. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/news/20170209/Loss-of-Golgi-function-may-contribute-to-pathology-of-neurodegenerative-diseases.aspx.

  • MLA

    The University of Manchester. "Loss of Golgi function may contribute to pathology of neurodegenerative diseases". News-Medical. 21 November 2024. <https://www.news-medical.net/news/20170209/Loss-of-Golgi-function-may-contribute-to-pathology-of-neurodegenerative-diseases.aspx>.

  • Chicago

    The University of Manchester. "Loss of Golgi function may contribute to pathology of neurodegenerative diseases". News-Medical. https://www.news-medical.net/news/20170209/Loss-of-Golgi-function-may-contribute-to-pathology-of-neurodegenerative-diseases.aspx. (accessed November 21, 2024).

  • Harvard

    The University of Manchester. 2019. Loss of Golgi function may contribute to pathology of neurodegenerative diseases. News-Medical, viewed 21 November 2024, https://www.news-medical.net/news/20170209/Loss-of-Golgi-function-may-contribute-to-pathology-of-neurodegenerative-diseases.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Careful counselling from clinicians may help alleviate anxiety in wAMD patients